COURSE DESCRIPTION:
A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered oncology care.

TARGET AUDIENCE:
Dermatology Oncology, Medical Oncologists, Radiation Oncologists, Surgical Oncology, General Surgeons, Pathologists, Radiologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists, Clinical Geneticist, Clinical Genetics Counselors, and all other healthcare personnel involved in the care of cancer patients.
 
EDUCATIONAL OBJECTIVES:

• Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach.
• Leverage interprofessional group discussion to review prospective patient care management, national treatment guidelines, staging, options and eligibility for genetic testing, clinical research studies, and supportive care services.
• Develop a comprehensive treatment plan for dermatology oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance.

FACULTY:

Naiara Braghiroli, MD, PhD, IFAAD
Chief of Skin Cancer and Pigmented Lesions Clinic 
Department of Dermatology
Miami Cancer Institute, Baptist Health South Florida
Miami, Florida

Guilherme Rabinowits, MD
Head & Neck, Endocrine and Cutaneous Medical Oncology
Co-Leader, Head and Neck Disease Management Team
Miami Cancer Institute, Baptist Health South Florida
Miami, Florida

Guilherme Rabinowits, M.D., conference director/moderator of this educational activity, is an advisee for Sanofi-Genzyme, Regeneron, Castle and Boston Gene. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Naiara Braghiroli, MD, PhD, conference director/moderator for this activity has no financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

 DMT coordinators and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

Disclosure Policy and Disclaimer

ACCREDITATION:
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.    

Baptist Health South Florida designates these live activities for a maximum of 1 AMA PRA Category 1 Credit™. each.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

These activities have been approved for 1 credit hour, CE Broker Course #20-989642, by the Florida Boards of Medicine and Osteopathic Medicine.